# IGC Pharma, Inc.: Form 8-K, filed Dec 15, 2025

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2025-12-15
- Accepted by EDGAR: Dec 15, 2025, 16:02 ET
- Period: 2025-12-12
- Accession: 0001185185-25-002055
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518525002055/igc8k121525.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518525002055/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518525002055/igc8k121525.htm

Filed Dec 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001185185-25-002055. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.